Browsing: pricing and reimbursement
Cobenfy (xanomeline/trospium chloride; formerly KarXT) was approved for schizophrenia in adults by the Food and Drug Administration in late September.…
Precision medicine’s promise is selecting the right drug for the appropriate person in a timely manner. But besides cancer, in…
Two weeks ago, the Food and Drug Administration approved Xolair (omalizumab) for immunoglobulin E-mediated food allergy in certain adults and…